The offering is a dilutive capital raise at a 20% discount, directly tied to the company's need to meet conditions for the Perceptive Sixth Amendment (a $15M prepayment due by Nov 30, 2026). Monitor whether the amendment conditions are satisfied by the deadline, as failure would reinstate the original revenue covenants that triggered the going concern warning. The Q3 earnings beat provides some near-term support, but the equity raise signals management's view that the company cannot generate sufficient cash internally to service its high-cost debt.
STIM drugs
STIM drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $1.43entry
- T+1 · 4d ago −2.80%α −2.43% · $1.39
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Neuronetics priced a $30M underwritten offering of 18.75M shares at $1.60/share, a 20.4% discount to the $2.01 last sale price. Proceeds will partially repay the $65M Perceptive credit facility (11.5% interest) and fund general corporate purposes. The filing follows Q3 revenue of $42.0M (+12.5% YoY) and a going concern warning tied to revenue covenant compliance.
Key Financial Metrics
Key Facts
- 18,750,000 shares offered at $1.60/share, a 20.4% discount to the $2.01 last reported sale price on Nov 10, 2026
- Total offering size of $30M; net proceeds estimated at $27.7M ($31.9M if underwriters exercise 30-day option for 2,812,500 additional shares)
- Dilution of 24.1% based on 77,728,311 shares outstanding as of Sep 30, 2026; post-offering shares would be 96,478,311 (or 99,290,811 with full option exercise)
- Proceeds to partially repay the $65M outstanding Perceptive Facility (11.5% interest, matures Jul 2029) and for general corporate purposes
- Company disclosed substantial doubt about ability to continue as a going concern due to projected trailing 12-month revenue falling below minimum required revenue covenants
- Perceptive Sixth Amendment (Nov 5, 2026) modifies revenue covenants but requires a $15M prepayment by Nov 30, 2026 or it terminates
- Q3 2026 revenue of $42.0M (+12.5% YoY) and GAAP EPS of -$0.02 beat consensus of $40.4M and -$0.11, respectively
- Underwriters: William Blair (lead), BTIG, Canaccord Genuity; 90-day lock-up for company and insiders
- Directors indicated interest in purchasing shares at the public offering price
Financial Impact
$30M gross proceeds from offering; net $27.7M after underwriting discounts and expenses; 24.1% dilution to existing shareholders
Risk Factors
- Going concern risk: substantial doubt about ability to continue as a going concern if revenue covenant compliance is not achieved
- Perceptive Sixth Amendment may terminate on Nov 30, 2026 if conditions (including $15M prepayment) are not satisfied or waived
- 24.1% dilution from the offering, with potential for further dilution from the underwriters' option and outstanding equity awards
- High debt load ($65M at 11.5% interest) consumes cash flow; proceeds only partially address near-term liquidity needs
- Stock price may face continued pressure from the discounted offering and overhang of additional shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-457031 |
| Document: 0001193125-26-457031-index-headers.html | 0001193125-26-457031 |
| Document: 0001193125-26-457031-index.html | 0001193125-26-457031 |
| Document: 0001193125-26-457031.txt | 0001193125-26-457031 |
Track record
30 reports on STIM
6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +11.73% at T+1 after the Nov 10, 2026 report. 7 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13D/A Neutral 4/10 Entry price pending
- Nov 16, 2026today SC 13D/A Bearish 6/10 Entry price pending
- Nov 12, 20264d ago 8-K/A Bearish 5/10 Entry $1.39 to $1.25 Now $1.25 +10.07% ▲ +10.07% +8.16% vs SPY
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
- Nov 12, 20264d ago 424B5 Bearish 6/10 Viewing Entry $1.43 to $1.39 Now $1.25 +12.59% ▲ +2.80% +2.43% vs SPY
- Nov 10, 20265d ago Press Release Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 424B5 Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.62 to $1.43 Now $1.25 −22.84% ▼ −11.73% −11.37% vs SPY
- Nov 10, 20266d ago Press Release Bearish 6/10 Entry $1.62 to $1.43 Now $1.25 +22.84% ▲ +11.73% +11.37% vs SPY
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $2.01 to $1.62 Now $1.25 −37.81% ▼ −19.40% −20.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers